Malaria and Maternal Mortality In Gezira-Sudan
الملخص
The objectives of this study include:(1) to identify the magnitude of malaria as a cause of maternal mortality (MM) (2) to study the demographic characteristics of MM cases caused by malaria and (3) to identify the actual cause of MM due to malaria.
Methods: This is a six years hospital based retrospective review of hospital records of ladies died due to malaria in Wad Medani Teaching Hospital for Obstetrics and Gynaecology (WMTHOG), form1 January 1998 to 31 December 2003.
Results: malaria caused 10% to 40% of MM per year. The mean age was 27.57 years, most of them were primigravidae and from rural areas. 37.8% of the deaths occurred between 28 and 36 weak of gestation. The median duration of stay in hospital was two days. However 32.4% of deaths stayed for less than 24 hours that indicated severe and serious clinical presentations. The main causes of death due to malaria or its complication were: anaemia (24.3), cerebral malaria (21.6%), circulatory failure (12.51 ) and renal failure (8.1%). Others were pulmonary oedema , hyperpyrexia , puerperal psychosis , abortion , severe epistaxis , cardiac arrest , black water fever, electrolyte imbalance, and hepatic failure. The study recommended effective prevention of malaria and an intensive care approach in its management.
المراجع
1. United Nations, International Statistical Classification of Disease and Related Problems Code 10 (ICD-10)
2. Federal Ministry of Health Safe motherhood survey 1999..
3. El Gaddal AA. The experience of the Blue Nile Health Project in the control of malaria and other water associated disease: American Association for Advancement of science. Malaria and development in Africa. A cross-pectoral approach. Washington DC AAAS 1991
4. Malik EM, Khalafalla OM: Malaria in Sudan: past, present and the future. Gezira Journal of Health Sciences 2004, 1(suppl):47-51.
5. Mohammed AA, Abdel Raheem SI., and Elnour MH.. Maternal Deaths at Kasala New Hospita (Eastern Sudan) l. The Arab board of Medical Specialization Vol.4,No.2, 2002, 25-30 ISSN 1561-2017
6. Dafallah SE, El Agib FH, Bushra GO Maternal Mortality in a teaching hospital inSudan. Saud medical journal,2003,24:369-73.
7. Taha Umbali, M. A> Abusalab, Maternal Mortality at Omdurman Maternity Hospital and Omdurman Saudi Hoptal in Sudan from 1999-2001.Journal fo The Arab board of Medical Specialization Vol.6,No.1, 2004, 25-30 ISSN 1561-0217
8. El Gaddal AA, Malaria in Sudan In. Buct AA, ed proceeding of the conference on malaria in Africa. Washington. DC: American Institute Of biological science, 1986;156-9
9. Omer,A.H.S., (1978) species prevalence of Malaria in Northern Sudan And control by Mass chemoprophylaxis . Am. J. Trop. Med. Hyg,27; 858-863
10. WHO, Communicable Diseases Cluster, 1211 Geneva Switzerland Royal Society of Tropical Medicine Volume 92 Supplement 1 April 2000 INNS 0035-9203
11. McGregor iA: Epidememyology , malaria and pregnancy Am J Trop Med Hyg 1984,33:517-25
12. Nosten,F, ter Kuile,F.,Maclankiri,I.,Decludt,B.,& White, N.J.(1991).Malaria during pregnancy in an area of unstable endemicity. Transactions of the Royal Society of Tropical Medicune and Hygiene, 85, 424-429
13. Brabin B : an assessment of low birth weight risk in primiprarae as an indicator of malaria central in pregnancy. Int J Epidemiol 1991 20;276-83 .
14. Meeusen EN , Bischof RJ , Lee CS : Comparative T – cell responses during pregnancy in large animals and humans. Am J Report Immunol 2001 , 46 : 169 – 79 .
15. Fried M, Duffy PE ; Adherence of plasmodium falciparum to chondroitin sulphate A in the human placenta. Science 1996, 227 : 1502 – 4 .
16. Beeson JG Rogers on SJ , Cooke BM , Reeder JC , Chi W , Lawson AM , Molyneux ME , Brwn GV : Adhesion of plasmodium falciparum infected erythrocytes to hyaluronic acid in placental malaria. Nat. Med 2000, 6:86-90 .
17. Maubert B , Fievet N , Tami G , Cot M , Boudinc , Deloron P : Development of antibodies against chondroitin sulphate A – adherent to plasmodium. falciparum in pregnant women. Infect immune 1999 , 67 : 5367 – 71
18. www.cdc. Gov/malaria/pregnancy.htm sited on 2 October 2007
19. UNICEF Malaria Technical Note 3 February 2003 .
20. Liaison Bulletin of the Malaria Programme WHO/AFRO Vol.3 No 1 .
21. Sakina BElamin,Elfatih M Malik,Tarig Abdelgadir,Ammar H Khamiss, Mamoun M Mahammed,Elderderi Ahmed, and Ishag Adam.Artesunate plus Sulfadoxine- Pyrimethamine for the trearment of uncomplicated Plasmodium falciparum malaria in Sudan. Malaria Journal www.Malaeiajournal.com/content /4/1/41. Sited on 25 September 2007.
22. Pepublic of Sudan Fedral Ministy of Health, National Malaria control Programme- The National Protocol for Treatment of Malaria.June 2004
23. Garner P, Gulmezoglu AM. Prevaetion versus treatment for malaria in pregnant women. Cochrane Data base System Aev202;(2):CD000 169.
24. Imad Eldin Elgack, Ahmed A/Alla Mohamadani and Omer Ahmed Mirghani, Malaria Prophylaxis During Pregnancy In Primigravidae Using Sulfadoxine- pyrimethamine In Wad Medani-Sudan. Jezira Journal of Medical Sciences Volume 1 number 1 September 2003.
